Florida Senate - 2014 COMMITTEE AMENDMENT Bill No. CS for SB 702 Ì610012UÎ610012 LEGISLATIVE ACTION Senate . House Comm: RCS . 04/02/2014 . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— 1 Senate Amendment (with title amendment) 2 3 Delete lines 28 - 72 4 and insert: 5 (b) To have the on-site audit scheduled after the first 3 6 calendar days of a month unless the pharmacist consents 7 otherwise. 8 (c) To have the audit period limited to 24 months after the 9 date a claim is submitted to or adjudicated by the entity. 10 (d) To have an audit that requires clinical or professional 11 judgment conducted by or in consultation with a pharmacist. 12 (e) To use the written and verifiable records of a 13 hospital, physician, or other authorized practitioner, which are 14 transmitted by any means of communication, to validate the 15 pharmacy records in accordance with state and federal law. 16 (f) To be reimbursed for a claim that was retroactively 17 denied for a clerical error, typographical error, scrivener’s 18 error, or computer error if the prescription was properly and 19 correctly dispensed, unless a pattern of such errors exists, 20 fraudulent billing is alleged, or the error results in actual 21 financial loss to the entity. 22 (g) To receive the preliminary audit report within 120 days 23 after the conclusion of the audit. 24 (h) To produce documentation to address a discrepancy or 25 audit finding within 10 business days after the preliminary 26 audit report is delivered to the pharmacy. 27 (i) To receive the final audit report within 6 months after 28 receiving the preliminary audit report. 29 (j) To have recoupment or penalties based on actual 30 overpayments and not according to the accounting practice of 31 extrapolation. 32 (2) The rights contained in this section do not apply to: 33 (a) Audits in which suspected fraudulent activity or other 34 intentional or wilful misrepresentation is evidenced by a 35 physical review, review of claims data or statements, or other 36 investigative methods. 37 (b) Audits of claims paid for by federally funded programs; 38 (c) Concurrent reviews or desk audits that occur within 3 39 business days of transmission of a claim and where no chargeback 40 or recoupment is demanded; or 41 (d) Audits related to fee-for-service claims under the 42 Medicaid program. 43 (3) An entity that audits a pharmacy located within a 44 Health Care Fraud Prevention and Enforcement Action Team (HEAT) 45 Task Force area designated by the United States Department of 46 Health and Human Services and the United States Department of 47 Justice may dispense with the notice requirements of paragraph 48 (1)(a) if such pharmacy has been a member of a provider network 49 for less than 12 months. 50 Section 2. This act shall take effect October 1, 2014. 51 52 ================= T I T L E A M E N D M E N T ================ 53 And the title is amended as follows: 54 Delete lines 5 - 11 55 and insert: 56 are conducted by certain entities; providing a list of 57 audits not subject to such rights; providing an 58 exemption from the right to notice of an on-site audit 59 under certain circumstances; providing an effective